According to CDC1, 1 in 3 adults in USA are prediabetics (over 88 million). And 80% them don’t even know they have it! Many people with prediabetes could develop type 2 diabetes within 5 years if they don’t do anything about it.  Elevated glycemic markers are a major risk factor for heart disease, which is the most common cause of death among adults with diabetes mellitus.  South Asians' Double Jeopardy  Diabetes is 2 to 4 times more prevalent amongst South Asians.  South Asians develop diabetes 10 to 15 years earlier than Caucasians.   And 80% of diabetics die of heart disease    You may have heard that before, but risks of this illness can be mitigated or even reversed. It's true!    Come join us for a FREE Educational Webinar that contrasts reality and theory  Preventing type 2 Diabetes: From Theory to Reality  By Dr Vanita Aroda, Director, Diabetes Clinical Research, Brigham and Women’s Hospital, Harvard Medical School  and  AIM to Prevent program   Mr. Amit Akkad, Director ICC and Lifestyle Program Ambassador  on Saturday May 1st, 2021, at 10 AM Eastern US time  What you will learn  Understand the evidence behind lifestyle intervention or metformin in the prevention of type 2 diabetes  Know long-term effects of efforts to prevent type 2 diabetes  Learn about the relationship of blood sugar control and long-term cardiovascular health   Registration is required to attend. Click here to register Please feel free to email us at lifestyle@ouricc.org if you have any questions about the webinar or the topics to be covered. Looking forward to seeing you soon! follow us on Facebook - like our page - https://www.facebook.com/IndianCircleforCaring  ICC Lifestyle Management Program Team www.ouricc.org

Speakers for this webinar Dr. Vanita Aroda, Director, Diabetes Clinical Research, Brigham and Women's Hospital, Harvard Medical School Dr Vanita Aroda is the Director of Diabetes Clinical Research at the Brigham and Women's Hospital in Boston, MA, and is Member of the Faculty of Harvard Medical School.  Dr. Aroda has an interest and published record in diabetes prevention and novel therapeutics in diabetes and weight management. She also has a strong interest in understanding therapeutic interventions in large Phase 3 and 4 clinical trials and their applicability and integration into care. Dr. Aroda has years of experience in clinical trial conduct and leadership, has served asan investigator on the National Institutes of Health-funded GRADE, D2d, and DPPOS studies, and as the national or international signatory Principal Investigator for several phase 3 clinical trials.  Mr. Amit Akkad, ICC Director and Lifestyle Program Ambassador Mr. Amit Akkad is an Experienced Global Services Executive, currently working as VP of Operations at Ava Robotics with proven track record of growing profitable service revenues with excellent customer satisfaction. Recognized as an IT services expert. A leader with excellent strategic, analytical, communications and operational skills. Mr. Akkad is Director of ICC and Lifestyle Ambassador serving community over the past couple of years.  He also works with multiple organizations to educate and inspire children of rural communities (Adivasi) in India for past few years.   Resources  CDC - On Your Way to Preventing Type 2 Diabetes  About Prediabetics and Type 2 Diabetes

|